The pharma giant will also receive a 1% royalty on future U.S. sales of influenza, Covid-19 and other related combination mRNA vaccine products made by BioNTech and Pfizer.
https://www.wsj.com/health/pharma/gsk-to-receive-370-million-in-u-s-patent-litigation-settlement-0a62d004?mod=pls_whats_news_us_business_f